Bristol-Myers Squibb (NYSE:BMY) Price Target Cut to $48.00 :

Bristol-Myers Squibb (NYSE:BMY – Get Free Report) had its target price dropped by stock analysts at BMO Capital Markets from $55.00 to $48.00 in a research report issued to clients and investors on Friday, Benzinga reports. The brokerage presently has a “market perform” rating on the biopharmaceutical company’s stock. BMO Capital Markets’ price objective would […]

Related Keywords

United States , Blue Bell , Pennsylvania , Philadelphia , America , Societe Generale , Pomalyst Imnovid , Redburn Atlantic , Bristol Myers Squibb , Milestone Investment Advisors , Bristol Myers Squibb Company Profile , Wells Fargo Company , Accordant Advisory Group Inc , Bristol Myers Squibb Company , Blue Bell Private Wealth Management , Get Free Report , Myers Squibb , Asset Management , Investment Advisors , Financial Advisors , Bell Private Wealth Management , Myers Squibb Company , Bristol Myers Squibb Daily , Nyse Bmy , Bmy , Medical , 11012210 , Lower Price Target , Bmo Capital Markets ,